Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/37613
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_DifferentClinicalGuideline.pdf492,54 kBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorSantana, Rafael Santos-
dc.contributor.authorLupatini, Evandro de Oliveira-
dc.contributor.authorZanghelini, Fernando-
dc.contributor.authorRonsoni, Ricardo de March-
dc.contributor.authorRech, Norberto-
dc.contributor.authorLeite, Silvana Nair-
dc.date.accessioned2020-04-29T12:56:17Z-
dc.date.available2020-04-29T12:56:17Z-
dc.date.issued2018-10-17-
dc.identifier.citationSANTANA, Rafael Santos et al. The different clinical guideline standards in Brazil: high cost treatment diseases versus poverty-related diseases. Plos One, v. 13, n. 10, e0204723. DOI: https://doi.org/10.1371/journal.pone.0204723. Disponível em: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0204723. Acesso em: 29 abr. 2020.pt_BR
dc.identifier.urihttps://repositorio.unb.br/handle/10482/37613-
dc.language.isoInglêspt_BR
dc.publisherPlos Onept_BR
dc.rightsAcesso Abertopt_BR
dc.titleThe different clinical guideline standards in Brazil : high cost treatment diseases versus poverty-related diseasespt_BR
dc.typeArtigopt_BR
dc.subject.keywordDoençaspt_BR
dc.subject.keywordPobrezapt_BR
dc.subject.keywordSaúde pública - Brasilpt_BR
dc.subject.keywordDiretrizes clínicas - Brasilpt_BR
dc.rights.license© 2018 Santana et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.pt_BR
dc.description.abstract1Each year, evidence-based clinical guidelines gain more space in the health professionals’ practice and in services organization. Due to the scarcity of scientific publications focused on diseases of poverty, the development of well-founded clinical guidelines becomes more and more important. In view of that, this paper aims to evaluate the quality of Brazilian guidelines for those diseases. The AGREE II method was used to evaluate 16 guidelines for poverty-related diseases (PRD) and 16 guidelines for global diseases whose treatment require high-cost technologies (HCD), with the ultimate aim of comparing the results. It was found that, in general, the guideline development quality standard is higher for the HCD guidelines than for the PRD guidelines, with emphasis on the "rigour of development" (48% and 7%) and "editorial independence" (43% and 1%) domains, respectively, which had the greatest discrepancies. The HCD guidelines showed results close to or above international averages, whereas the PRD guidelines showed lower results in the 6 domains evaluated. It can be concluded that clinical protocol development priorities need some redirecting in order to qualify the guidelines that define the healthcare organization and the care of vulnerable populations.pt_BR
dc.identifier.orcidhttp://orcid.org/0000-0002-5258-9684pt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.